line
line
line
line
line
line
line

2018 BioMAN Summit

Agenda for Day 2: December 12, 2018

line
7:45-8:30 AM—Breakfast
line
8:30-8:35 AM—Welcome and Introduction
line
  Stacy L. Springs
Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI
line
8:35-9:45 AM—Keynote Presentations
line
  Presentation on Investing in the State of Innovation
Travis McCready
President and CEO, Massachusetts Life Science Center
line
  Presentation on Gene Therapy
Guangping Gao
Professor Department of Microbiology and Physiological Systems, University of Massachusetts Medical School
line
9:45-10:05 AM—Framing the Day
line
  Meeting the Challenges of Manufacturing Advanced Therapies
Jacqueline Wolfrum
Associate Director, Biomanufacturing Program, MIT CBI
line
10:05 AM-12:20 PM—New Platforms
line
  Presentation on Small-Scale Manufacturing Platforms
Greg Russotti
Vice President, Cell Therapy Technical Development, Celgene
line
  Expansion of Human iPSC in Stirred Suspension Culture
Aletta Schnitzler
Head of Collaborations, MilliporeSigma
line
  High-titer LV Production in Suspension Cell Culture Systems Using Transient Transfection
Onur Kas
Senior Scientist, Virus and Gene Therapy Bioprocessing, MilliporeSigma
line
  Technologies for High-Quality Manufacturing of Autologous Cell Therapies
Rajeev Ram
Professor, Electrical Engineering,
MIT

Harry Lee
President and Co-Founder,
Pharyx
line
  Presentation on Automated Platform for iPSC Generation, Editing, and Testing
Elizabeth Schwarzbach
Chief Business Officer, New York Stem Cell Foundation Research Institute
line
12:20-1:20 PM—Lunch
line
1:20-5:00 PM—Session 4: New Challenges
line
  Presentation on Biophysical Characterization of Cell Therapies
Colin Hebert
Vice President of Biotechnology, Lumacyte
line
  Presentation on Characterization of Viral Vector Titer
Vivian Choi
Head of Gene Therapy Research, Shire
line
  Presentation on Characterization of Autologous Cell Therapies
Trent Munro
Executive Director of Process Development, Amgen
line
  Presentation on Novel Technology for Rapid Microbial Detection
Speaker To Be Determined, Fluid-Screen
line
  Presentation on Label-Free Cell Characterization
Krystyn Van Vliet
Associate Provost; Professor, Materials Science and Engineering and Biological Engineering, MIT
line
  Presentation on Challenges and Opportunities in AAV Manufacturing for Gene Therapies
Nicole Paulk
Assistant Professor, Biochemistry and Biophysics, University of California, San Francisco
line
  Lessons from the CAACB for Cell and Gene Therapy Products
Paul Barone
Director, Consortium on Adventitious Agent Contamination in Biomanufacturing, MIT CBI
line
  Presentation on the Financing of Cures in the US Project
Casey Quinn
Research Advisor, NEWDIGS FoCUS Project, MIT CBI
line
5:00-5:10 PM—Day 2 Closing Remarks
line
  Stacy L. Springs
Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI
line
bottom line
MIT CBI BioMAN